DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20191701

A study on serum lipid and malondialdehyde levels among diabetic patients

S. C. Vivekananthan, M. Suresh Kumar, Saranya Nagalingam

Abstract


Background: Elevated levels of lipid peroxide in diabetes mellitus may be due to the alteration of function of erythrocytes membrane. This inhibits the activity of superoxide dismutase enzyme leading to accumulation of superoxide radicals which cause the maximum lipid peroxidation and tissue damage in diabetes. The objectives was to study was done with the objectives of assessing the serum lipid and malondialdehyde levels among diabetic population and matched control group.

Methods: This study was done among 50 NIDDM, 50 IDDM and 50 controls at Thanjavur Medical College, Tamil Nadu, India for a period of one year at the Department of Diabetology after getting the informed consent and IEC clearance. This study included all ambulatory NIDDM and IDDM patients without any complications. The following investigations like serum malondialdehyde, blood sugar, HBA1C, serum lipid profile, blood urea, serum creatinine, urine albumin and sugar were done by standardized procedures and reagents after getting the detailed history and examination.

Results: Among NIDDM group 78% were between 6.4 to 8 categories whereas in IDDM group only 28% were in this 6.4 to 8 category (HBA1C). Comparison of serum MDA values among three groups were done by ANOVA with two groups separately and it was highly significant. Multiple comparison of mean difference of MDA and lipid values among all the three groups showed statistically significant results with p value at 0.05.

Conclusions: Lipid profile is increased in poor glycemic controlled patients (both IDDM and NIDDM patients) and it is reflected in high serum malondialdehyde levels.


Keywords


Glycemic status, HBA1C, IDDM, NIDDM, Serum lipid levels, Serum malondialdehyde

Full Text:

PDF

References


Bishop ML, Fody EP, Schoeff LE. Clinical Chemistry Technique: Principle correlations. 6th ed. Woltees Kluwee (India) New Delhi; 2009: 13;314.

Altomare E, Vendemiale G, Chicco D, Procacci V, Cirelli F. Increased lipid peroxidation in type 2 poorly controlled diabetic patients. Diabete & metabolisme. 1992;18(4):264-71.

K Park. Park’s text book of preventive and social Medicine. 20th ed. 2009;6:342-343.

Burtis CA, Ashwood ER, Bruns DE. Tietz text book of clinical chemistry and molecular diagnostics. 2012; 25: 854.

Anderson SC, Cockayne S. Clinical chemistry concept and applications. 2003: 10; 159.

Rask-Madsen C, King GL. Vascular complications of diabetes: mechanisms of injury and protective factors. Cell Metab. 2013;17(1):20-33.

Lester Packer, Peter Rosen, Chler HJT, King GL, Angelo A. Antioxidants in diabetes management. UNESCO MCBN 15A. 2000;3:42-5.

Agarwal S, Baneejee S, Chattejee SN. Effects of oxygen and ferrous sulphate induced lipid peroxidation in liposomae membrane. Ind J Biochem Biophysics. 1985;21:331-4.

Chattergee SN, Agarwal S, Amitkumar, Membrane lipid peroxidation and its pathological consequence. Ind J Biochem Biophysics. 1988;25:31.

Steiner G. Arthroscleroses, the major complication of diabetes. In: urnaic M, Hollenberg CH, Steriner G, eds. Comparison of type 1 and type 11 Diabetes: Similarities and Dissimilates in etiology, Pathogenesis and Complications. New York: Plenum press: 1985; 277-297.

Marshall WT, Bangert SK. Clinical Biochemistry, Metabolic and Clinical aspects, 2nd ed. Churchill Livingstone; 2008: 946-947.

Suryawanshi NP, Bhutey AK, Nagdeote AN, Jadhav AA, Manoorkar GS. Study of lipid peroxide and lipid profile in Diabetes Mellitus. Ind J Clin Biochem. 2006;21:126-30.

Sayday SH, Ebarhardt, MS, Loria cm. Age and burden of death attributable to diabetes in the united states. Am Epideiol. 2002;156:714-9.

Harmel AP, Mathur R. Davinson’s diabetes mellitus diagnosis and treatment, 5th ed. 2004; 8: 246.

Cathcard MK, Folcik VA. Lipoxygenases and atherosclerosis. Protection versus pathogenesis. Free Radic Biol Med. 2000;28:1726-34.

Kuhn H, Chan L, The role of 15-Lipoxygenase in atherogenesis; pro and antiaatherogenic actions, Curropin Lipidol. 1997;8:111-17.

Yia-Herttuala S, Palinski W, Rosenfeld ME. Evidence for the presence of oxidatively modified low-density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest. 1989;84:1086-95.

Parthasarathy S, Rankin SM. Role of oxidized LDL in atherogenesis. Prog Lipid Res. 1992:31:127-43.

Berliner TA, Navab M, Fogelman AM. Basic mechanisms oxidation, inflammation and genetics. Correlation. 1995;91:2488-96.

Berliner TA, Heinecke JW. The role of oxidized LP in atherogenesis. Free Rad Biol Med. 1996;20:707-27.

Steinberg D. Oxidative Modification of LDL and atherogenesis. Circulation. 1997;95:1062-71.